Is Dual Time Point Imaging Necessary For Discrimination of adrenal benign lesions versus malignant masses: A Study Comparing Standart Methods with Dual Time Point FDG PET-CT Imaging

dc.contributor.authorKara, P. Ozcan
dc.contributor.authorKoc, Z.
dc.contributor.authorKara, T.
dc.contributor.authorKaya, B.
dc.date.accessioned2024-02-23T14:45:21Z
dc.date.available2024-02-23T14:45:21Z
dc.date.issued2016
dc.departmentNEÜen_US
dc.descriptionAnnual Congress of the European-Association-of-Nuclear-Medicine -- OCT 15-19, 2016 -- Barcelona, SPAINen_US
dc.description.abstract[Abstract Not Availabe]en_US
dc.description.sponsorshipEuropean Assoc Nucl Meden_US
dc.identifier.endpageS443en_US
dc.identifier.issn1619-7070
dc.identifier.issn1619-7089
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpageS442en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12452/17385
dc.identifier.volume43en_US
dc.identifier.wosWOS:000391802400563en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherSpringeren_US
dc.relation.ispartofEuropean Journal Of Nuclear Medicine And Molecular Imagingen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject[Keyword Not Available]en_US
dc.titleIs Dual Time Point Imaging Necessary For Discrimination of adrenal benign lesions versus malignant masses: A Study Comparing Standart Methods with Dual Time Point FDG PET-CT Imagingen_US
dc.typeConference Objecten_US

Dosyalar